Cited by 35Malaria Research and ControlMonoclonal and Polyclonal Antibodies ResearchBlood groups and transfusion

Broadly inhibitory antibodies to severe malaria virulence proteins

Open access
Reyes, Raphael A., Raghavan, Sai Sundar Rajan, Hurlburt, Nicholas K., Introini, Viola, Bol, Sebastiaan, Kana, Ikhlaq Hussain, Jensen, Rasmus W., Martinez-Scholze, Elizabeth +21 more·2024·Nature

Published version of a preprint

Abstract

Malaria pathology is driven by the accumulation of Plasmodium falciparum-infected erythrocytes in microvessels 1. This process is mediated by the polymorphic erythrocyte membrane protein 1 (PfEMP1) adhesion proteins of the parasite. A subset of PfEMP1 variants that bind to human endothelial protein C receptor (EPCR) through their CIDRα1 domains is responsible for severe malaria pathogenesis 2. A longstanding question is whether individual antibodies can recognize the large repertoire of circulating PfEMP1 variants. Here we describe two broadly reactive and inhibitory human monoclonal antibodies to CIDRα1. The antibodies isolated from two different individuals exhibited similar and consistent EPCR-binding inhibition of diverse CIDRα1 domains, representing five of the six subclasses of CIDRα1. Both antibodies inhibited EPCR binding of both recombinant full-length and native PfEMP1 proteins, as well as parasite sequestration in bioengineered 3D human brain microvessels under physiologically relevant flow conditions. Structural analyses of the two antibodies in complex with three different CIDRα1 antigen variants reveal similar binding mechanisms that depend on interactions with three highly conserved amino acid residues of the EPCR-binding site in CIDRα1. These broadly reactive antibodies are likely to represent a common mechanism of acquired immunity to severe malaria and offer novel insights for the design of a vaccine or treatment targeting severe malaria.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-024-08220-3

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Reyes, R. A., Raghavan, S. S. R., Hurlburt, N. K., Introini, V., Bol, S., Kana, I. H., Jensen, R. W., Martinez-Scholze, E., Gestal-Mato, M., López-Gutiérrez, B., Sanz, S., Bancells, C., Fernández-Quintero, M. L., Loeffler, J. R., Ferguson, J. A., Lee, W.-H., Martin, G. M., Theander, T. G., Lusingu, J. P. A., Minja, D. T. R., Ssewanyana, I., Feeney, M. E., Greenhouse, B., Ward, A. B., Bernabeu, M., Pancera, M., Turner, L., Bunnik, E. M., & Lavstsen, T.
Affiliations
  • The University of Texas at San Antonio Health Science Center (US)
  • Scripps Research Institute (US)
  • Fred Hutch Cancer Center (US)
  • European Molecular Biology Laboratory (ES)
  • University of Copenhagen (DK)
  • National Institute for Medical Research (TZ)
  • Infectious Diseases Research Collaboration (UG)
  • University of California, San Francisco (US)
Corresponding author
  • Turner, Louise
  • Bunnik, Evelien M.
  • Lavstsen, Thomas
Venue
Nature
Published
2024-11-20
Volume
636
Issue
8041
Pages
182-189
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4404566626
Cited by
35
References
4
Citations by year
2026: 13 · 2025: 17 · 2024: 5
FWCI
14.50
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • PubMed Central (acceptedVersion)
  • PubMed Central (submittedVersion, cc-by-nc)
  • RePEc: Research Papers in Economics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • U.S. Department of Energy (-AC02-05CH11231, 05CH11231, DE AC02 05CH11231, DE-AC02-)
  • Cancer Prevention and Research Institute of Texas (RP210126, CA054174)
  • Wellcome Trust
  • European Molecular Biology Laboratory
  • Lundbeckfonden (R344-2020-934)
  • Novo Nordisk
  • Novo Nordisk Fonden (NNF23OC0086433)
  • H. Lundbeck A/S
  • National Institutes of Health (1s10od030432-01a1, DE-AC02–05CH11231, TL1TR002647, 1s10od028581-01, AI089674, CA054174)
  • Office of Science (DEAC02–05CH11231, AC02-05CH11231, DE-AC02)
  • University of Texas Health Science Center at San Antonio (TL1TR002647, P30 CA054174, TR002647)
  • National Cancer Institute (CA-054174, P30CA054174, DE-AC02-05CH11231)
  • National Institute of Allergy and Infectious Diseases (U01AI150741, K23AI076614, AI089674, F31AI169993, R01AI153425, R01AI093615, U19AI089674, K24AI144048)
  • National Center for Advancing Translational Sciences
  • Basic Energy Sciences (DE-AC02, DE-AC02-05CH11231., AC02–05CH11231)
  • H2020 Marie Skłodowska-Curie Actions
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
Keywords
severe malaria, Plasmodium falciparum, PfEMP1, monoclonal antibodies, endothelial protein C receptor, erythrocyte sequestration, cerebral microvasculature, adaptive immunity, antibody structure, vaccine design, malaria treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review